These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 17384676

  • 1. DUSP22/LMW-DSP2 regulates estrogen receptor-alpha-mediated signaling through dephosphorylation of Ser-118.
    Sekine Y, Ikeda O, Hayakawa Y, Tsuji S, Imoto S, Aoki N, Sugiyama K, Matsuda T.
    Oncogene; 2007 Sep 06; 26(41):6038-49. PubMed ID: 17384676
    [Abstract] [Full Text] [Related]

  • 2. Regulation of STAT3-mediated signaling by LMW-DSP2.
    Sekine Y, Tsuji S, Ikeda O, Sato N, Aoki N, Aoyama K, Sugiyama K, Matsuda T.
    Oncogene; 2006 Sep 21; 25(42):5801-6. PubMed ID: 16636663
    [Abstract] [Full Text] [Related]

  • 3. Estrogen negatively regulates epidermal growth factor (EGF)-mediated signal transducer and activator of transcription 5 signaling in human EGF family receptor-overexpressing breast cancer cells.
    Boerner JL, Gibson MA, Fox EM, Posner ED, Parsons SJ, Silva CM, Shupnik MA.
    Mol Endocrinol; 2005 Nov 21; 19(11):2660-70. PubMed ID: 15976008
    [Abstract] [Full Text] [Related]

  • 4. Regulation of c-Jun N-terminal kinase and p38 kinase pathways in endothelial cells.
    Wadgaonkar R, Pierce JW, Somnay K, Damico RL, Crow MT, Collins T, Garcia JG.
    Am J Respir Cell Mol Biol; 2004 Oct 21; 31(4):423-31. PubMed ID: 15231489
    [Abstract] [Full Text] [Related]

  • 5. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
    Zheng J, Kulp SK, Zhang Y, Sugimoto Y, Dayton MA, Govindan MV, Brueggemeier RW, Lin YC.
    Anticancer Res; 2000 Oct 21; 20(1A):11-9. PubMed ID: 10769629
    [Abstract] [Full Text] [Related]

  • 6. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
    Gilad LA, Bresler T, Gnainsky J, Smirnoff P, Schwartz B.
    J Endocrinol; 2005 Jun 21; 185(3):577-92. PubMed ID: 15930183
    [Abstract] [Full Text] [Related]

  • 7. Protein phosphatase 5 is a negative regulator of estrogen receptor-mediated transcription.
    Ikeda K, Ogawa S, Tsukui T, Horie-Inoue K, Ouchi Y, Kato S, Muramatsu M, Inoue S.
    Mol Endocrinol; 2004 May 21; 18(5):1131-43. PubMed ID: 14764652
    [Abstract] [Full Text] [Related]

  • 8. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
    Lee YR, Park J, Yu HN, Kim JS, Youn HJ, Jung SH.
    Biochem Biophys Res Commun; 2005 Nov 04; 336(4):1221-6. PubMed ID: 16169518
    [Abstract] [Full Text] [Related]

  • 9. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
    Hermani A, Shukla A, Medunjanin S, Werner H, Mayer D.
    Cell Signal; 2013 Jun 04; 25(6):1395-402. PubMed ID: 23499909
    [Abstract] [Full Text] [Related]

  • 10. Expression of estrogen receptor alpha, retinoic acid receptor alpha and cellular retinoic acid binding protein II genes is coordinately regulated in human breast cancer cells.
    Lu M, Mira-y-Lopez R, Nakajo S, Nakaya K, Jing Y.
    Oncogene; 2005 Jun 23; 24(27):4362-9. PubMed ID: 15870697
    [Abstract] [Full Text] [Related]

  • 11. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
    Al-Dhaheri MH, Rowan BG.
    Mol Endocrinol; 2007 Feb 23; 21(2):439-56. PubMed ID: 17068199
    [Abstract] [Full Text] [Related]

  • 12. Glycogen synthase kinase-3 protects estrogen receptor alpha from proteasomal degradation and is required for full transcriptional activity of the receptor.
    Grisouard J, Medunjanin S, Hermani A, Shukla A, Mayer D.
    Mol Endocrinol; 2007 Oct 23; 21(10):2427-39. PubMed ID: 17609434
    [Abstract] [Full Text] [Related]

  • 13. Activation of antimetastatic Nm23-H1 gene expression by estrogen and its alpha-receptor.
    Lin KH, Wang WJ, Wu YH, Cheng SY.
    Endocrinology; 2002 Feb 23; 143(2):467-75. PubMed ID: 11796500
    [Abstract] [Full Text] [Related]

  • 14. Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity.
    Santen RJ, Song RX, Zhang Z, Kumar R, Jeng MH, Masamura A, Lawrence J, Berstein L, Yue W.
    Endocr Relat Cancer; 2005 Jul 23; 12 Suppl 1():S61-73. PubMed ID: 16113100
    [Abstract] [Full Text] [Related]

  • 15. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
    Phelps M, Darley M, Primrose JN, Blaydes JP.
    Cancer Res; 2003 May 15; 63(10):2616-23. PubMed ID: 12750288
    [Abstract] [Full Text] [Related]

  • 16. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R, Fatima I, Chandra V, Blesson CS, Kharkwal G, Hussain MK, Hajela K, Roy BG, Dwivedi A.
    Steroids; 2013 Nov 15; 78(11):1071-86. PubMed ID: 23891847
    [Abstract] [Full Text] [Related]

  • 17. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M.
    Cancer Res; 2002 Sep 01; 62(17):4977-84. PubMed ID: 12208749
    [Abstract] [Full Text] [Related]

  • 18. Rsk2 allosterically activates estrogen receptor alpha by docking to the hormone-binding domain.
    Clark DE, Poteet-Smith CE, Smith JA, Lannigan DA.
    EMBO J; 2001 Jul 02; 20(13):3484-94. PubMed ID: 11432835
    [Abstract] [Full Text] [Related]

  • 19. Estrogen receptor alpha binds to peroxisome proliferator-activated receptor response element and negatively interferes with peroxisome proliferator-activated receptor gamma signaling in breast cancer cells.
    Bonofiglio D, Gabriele S, Aquila S, Catalano S, Gentile M, Middea E, Giordano F, Andò S.
    Clin Cancer Res; 2005 Sep 01; 11(17):6139-47. PubMed ID: 16144913
    [Abstract] [Full Text] [Related]

  • 20. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.
    Oesterreich S, Zhang P, Guler RL, Sun X, Curran EM, Welshons WV, Osborne CK, Lee AV.
    Cancer Res; 2001 Aug 01; 61(15):5771-7. PubMed ID: 11479214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.